ZEVRA THERAPEUTICS INC
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
| Item 5. | Other Information |
|---|
(a) Disclosure in lieu of reporting on a Current Report on Form8-K.
None.
(b) Material changes to the procedures by which security holders* may*recommend nominees to the board of directors.
None.
(c) Insider Trading Arrangements and Policies.
During thethree months ended* June 30, 2024,no director or officer of the Company adopted or terminated a “Rule10b5*-1 trading arrangement” or “non-Rule10b5-1 trading arrangement,” as each term is defined in Item408(a) of Regulation S-K.
43
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.